MYX-135
/ DNAtrix
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 05, 2019
Synergy of CTL tumor cytotoxicity with myxoma oncolytic virotherapy
(AACR 2019)
- "Oncolytic myxoma virus infection can decrease the MHC class I expression in human breast cancer cell lines, but only at high multiplicities of infection. At low level of virus, myxoma virus infection can enhance CTL cytotoxcity of breast cancer cell line."
IO Biomarker • Oncolytic Virus • Tumor Mutational Burden
1 to 1
Of
1
Go to page
1